A Diagnostics & Imaging Week
Covidien (St. Louis) said one of its subsidiaries has signed an agreement to supply X-ray contrast imaging agents to customers of MedAssets Supply Chain Systems (St. Louis), a group purchasing organization.
Covidien said that the multi-year agreement broadens the scope of its Imaging Solutions products available to MedAssets Supply Chain Systems customers nationwide.
Covidien will provide products used to aid in the diagnosis of disease, including X-ray contrast agents, sodium chloride injection, USP 0.9% in Ultraject prefilled syringes and MD-Gastroview (diatrizoate meglumine and diatrizoate sodium solution, USP). Covidien Imaging Solutions also is supplying its portfolio of contrast media injectors to MedAssets' customers in accordance with a separate agreement signed earlier this year.
"Now, MedAssets' customers will be able to use our contrast imaging agents in combination with our injectors to more efficiently meet the needs of the healthcare provider and patient," said Rick Lytle, VP and general manager of Imaging — U.S.
In other agreements, Premier Purchasing Partners (Charlotte, North Carolina) reported a new deal has been signed for support services outsourcing of clinical technology services (CTS) with Aramark of Philadelphia.
The agreement offers discounted pricing for acute and continuum of care members of the Premier alliance.
Premier also reported that Hologic (Bedford, Massachusetts) has been awarded new agreements for mammography and bone densitometry products and point of sale service agreements.
The contracts with Hologic, effective Nov. 1, are available to acute and continuum of care members of the Premier healthcare alliance.
Premier serves 1,700 hospitals and more than 49,000 other healthcare sites.